Contact
Editorial Inquiries
Questions, citation corrections, and feedback for Tesamorelin Compound.
How to Reach Us
Tesamorelin Compound is an independent editorial digest of the peer-reviewed literature on Tesamorelin, the FDA-approved GHRH analogue.
We welcome:
- Citation corrections: If you identify an error in a cited DOI, PMID, or quoted quantitative finding, we want to know. Editorial accuracy is the site's primary obligation.
- Research updates: If a relevant published trial has been omitted from the digest, please send the full citation.
- Editorial feedback: General questions about site structure or content coverage.
We do not provide:
- Medical advice, clinical consultations, or recommendations on human administration of any compound
- Dosage guidance for individuals
- Referrals to clinics, vendors, or prescribers
This site does not sell any product and has no commercial relationship with any compounding pharmacy, clinical provider, or peptide vendor.
To contact the editorial team, use the form below. We respond to factual correction requests as a priority. Response times for general feedback may vary.